Topic Review
Microbial Biosurfactants
Surface-active molecules also known as surfactants are chemicals that have key impacts on several aspects of our daily products and life. Most of these chemical surfactants originate from petrochemical of oleochemical sources and are ingredients of household laundry cleaning agents, cosmetics, pharmaceutical, environmental cleaning products, petroleum, and agro-food processing industry. Worldwide use of these compounds has been steadily increasing during the past few decades and will be further increasing in the future.  Most such chemical surfactants  however, have negative effects on the environment, a fact that led to the search for alternatives with less impact and the shift towards a more sustainable environmental friendly biological surfactants (biosurfactants) which was mainly driven by the sustainability agenda by many international players in the field. Most these biosurfactants are produced by microorganisms (bacteria and fungi) and the advantages they bring include much lower toxicity, relative stability at high temperature and in adverse environments in addition to being readily biodegradable when, discharged into the environment. Many chemical surfactants included in cosmetic and pharmaceutical compounds have been reported to have the potential to cause detrimental effects such as allergic reactions and skin irritations to the human skin which encouraged the search for a more suitable replacements  with less or no negative effects on skin health. As biosurfactants were known to exhibit skin compatibility, protection and surface moisturizing effects which are key components for an effective skincare routine in addition to lower toxicity. Interest therefore in biosurfactants that have antimicrobial, skin surface moisturizing and low toxicity properties which would make them suitable substitutes for chemical surfactants in current cosmetic and personal skincare and pharmaceutical formulations has been steadily increasing. 
  • 801
  • 24 Mar 2023
Topic Review
Micro- and Nanosized Carriers for Nose-to-Brain Drug Delivery
The intranasal route of drug administration offers numerous advantages, such as bypassing the intestine, avoiding first-pass metabolism, and reducing systemic side effects. Moreover, it circumvents the BBB, providing direct entrance to the brain through the olfactory and trigeminal nerve pathways.  Micro- and nanotechnological approaches were widely used to overcome these limitations and enhance the availability of drugs in the brain tissue. Micro- and nanoparticulate carriers are composed of natural or synthetic materials that interact with biological structures at the molecular level and lead the treatment of NDs into a new direction. They may induce interaction between target sites, thus minimizing the side effects.
  • 589
  • 22 Aug 2022
Topic Review
MGluRI and ErbB Receptors
It is well-appreciated that phosphorylation is an essential post-translational mechanism of regulation for several proteins, including group 1 metabotropic glutamate receptors (mGluRI), mGluR1 and mGluR5 subtypes. While contributions of various serine/threonine protein kinases on mGluRI modulation have been recognized, the functional role of tyrosine kinases (TKs) is less acknowledged. Here, we describe current evidence on the modulatory roles of the ErbB tyrosine kinases receptors - activated by the neurotrophic factors neuregulins (NRGs) - on mGluRI function. Available evidence suggests that mGluRI activity is tightly dependent on ErbB signaling, and that ErbB's modulation profoundly influences mGluRI-dependent effects on neurotransmission, neuronal excitability, synaptic plasticity, and learning and memory processes. 
  • 969
  • 13 Nov 2020
Topic Review
Mexican Plants with Teratogenic Effects
In Mexico, the use of medicinal plants is the first alternative to treat the diseases of the most economically vulnerable population. Some species with teratogenic effects and the main alterations that were found in the nervous system and axial skeleton, induced by compounds such as alkaloids, terpenes, and flavonoids. 
  • 503
  • 08 Jul 2022
Topic Review
Mexican Medicinal Plants
Some natural compounds belonging to the group of Mexican medicinal plants or “Mexican folk medicine”are  used for pain management in Mexico.
  • 541
  • 14 May 2021
Topic Review
Mevalonate Kinase Deficiency and Squalene Synthase Inhibitor (TAK-475)
Mevalonate Kinase Deficiency (MKD) is a rare inborn disease belonging to the family of periodic fever syndromes. The MKD phenotype is characterized by systemic inflammation involving multiple organs, including the nervous system. Current anti-inflammatory approaches to MKD are only partially effective and do not act specifically on neural inflammation. According to the new emerging pharmacology trends, the repositioning of drugs from the indication for which they were originally intended to another one can make mechanistic-based medications easily available to treat rare diseases. According to this perspective, the squalene synthase inhibitor Lapaquistat (TAK-475), originally developed as a cholesterol-lowering drug, might find a new indication in MKD, by modulating the mevalonate cholesterol pathway, increasing the availability of anti-inflammatory isoprenoid intermediates.
  • 575
  • 19 Oct 2021
Topic Review
Methotrexate
Methotrexate (MTX), a structural analogue of folic acid, that inhibits cell division (mainly in the S phase of the cell cycle) is commonly used for the treatment of many cancers as well for severe and resistant forms of autoimmune pathologies and inflammatory disorders. This paragraph of clinical overview presents state of knowledge with regards to different pathways of MTX active transport system, mechanisms of action and its applications as immunosuppressive drug and anticancer agent.  
  • 3.0K
  • 28 Oct 2020
Topic Review
Methods for DDIs Mediated by Renal Transporters
Drug–drug interactions (DDIs) are a key issue in clinical rational administration and post-marketing pharmacovigilance. Since the 1980s, with the development of molecular biology, the study of renal transporters has made rapid progress. The exploration of these transporters has helped to improve drug safety and efficacy, played an important role in understanding drug toxicity and DDIs, and also provided a theoretical basis for improving drug targeting. Regarding renal transporters, researchers and drug discovery scientists have studied a lot in the field of their mediated DDIs, from traditional models to recent biomarker methods and in silico models.
  • 292
  • 21 Jul 2023
Topic Review
Methodologies for the physico-chemical characterization of biopharmaceuticals
Biopharmaceuticals are medicinal products obtained by biotechnological processes using molecular biology methods, which include proteins, sugars, nucleic acids, cells, tissues, used for therapeutic or diagnostic purposes in vivo. Genetically modified plants, animals, or microorganisms are also potentially used to produce biopharmaceuticals.
  • 370
  • 29 Mar 2022
Topic Review
Metformin in Type 2 Diabetes
Metformin is the most commonly used glucose-lowering therapy (GLT) worldwide and remains the first-line therapy for newly diagnosed individuals with type 2 diabetes (T2D) in management algorithms and guidelines after the UK Prospective Diabetes Study (UKPDS) showed cardiovascular mortality benefits in the overweight population using metformin.
  • 409
  • 21 Jan 2021
  • Page
  • of
  • 106
Video Production Service